 |
ProductsAntisoma has a diverse portfolio of products in development. Our products target tumours by several different mechanisms and are intended for the treatment of a range of cancers. 
Read more
|
Latest news
In focus
|
08/12/08 - Positive clinical data presented at ASH | |
|
14/10/08 - Antisoma Annual Report and Accounts | |
|
18/09/08 - Preliminary results presentation |
Share price
| 24.75 GBp |  1.00 |
| Date: | 05/01/2009 |
